INyX Contract Manufacturing of Dry Powder Inhalers (DPIs)

DPI products are primarily used for respiratory ailments such as asthma. However, this is also a mode of drug delivery that is enjoying increased use for other products such as those that target systemic disease, including insulin for diabetes and pain management drugs.

In producing DPIs, a semi-automatic process is used, which includes bulk manufacture, device assembly and printing, filling and packaging. Our annual output capacity for dry powder inhalers is currently in excess of two million units.